Search

Your search keyword '"HARA T"' showing total 431 results

Search Constraints

Start Over You searched for: Author "HARA T" Remove constraint Author: "HARA T" Publisher elsevier bv Remove constraint Publisher: elsevier bv
431 results on '"HARA T"'

Search Results

1. Effect of silica-based mesoporous nanomaterials on human blood cells

6. Economic crisis in Greece: The invisible enemy of blood donation or not?

8. The Importance of Relative Dose Intensity in S-1 Monotherapy as an Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study in Nagasaki, Japan

10. P47.14 Study Design of SCORPION: Multi-Center, Phase II Study Following Platinum-Based Chemotherapy Plus ICIs in Patients with NSCLC

18. P-178 Prognostic impact of immune-related adverse events with nivolumab or pembrolizumab monotherapy in patients with advanced gastric cancer: A multicenter retrospective analysis

19. Carbon Monoxide Diffusing Capacity Predicts Cardiac Readmission in Patients Undergoing Left Ventricular Assist Device Implantation

20. Measurement of D 0 – D ‾ 0 mixing and search for CP violation in D 0 → K + K − , π + π − decays with the full Belle data set

23. High Heart Rate and Pulmonary Vascular Resistance Predict Poor Prognosis after Referral for Lung Transplantation in Patients with Pulmonary Arterial Hypertension

29. Background-independent measurement of θ13 in Double Chooz

30. Global resuscitation alliance utstein recommendations for developing emergency care systems to improve cardiac arrest survival

32. Loss of the Martian atmosphere to space: Present-day loss rates determined from MAVEN observations and integrated loss through time

37. A novel phenotype of ALDH2 polymorphism: alcohol-induced skin pigmentation

38. Measurement of charm production in antineutrino charged-current interactions

39. First measurement of θ13 from delayed neutron capture on hydrogen in the Double Chooz experiment

40. Search for resonant B±→K±h→K±γγ decays at Belle

41. P2.03-032 Efficacy and Safety of Osimertinib as Third-Line or Later Therapy for T790M-Positive Advanced Non-Small Cell Lung Cancer

42. P1.03-010 Efficacy and Safety of Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitors in ALK-Positive Non-Small Cell Lung Cancer

43. S-1 and CPT-11 plus ramucirumab (IRIS+Rmab) as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: A multicenter phase II study in Japan (N-DOCC-F-C-1701)

46. Multicenter investigation for vena caval filter fractures

49. Safety insights from forensics evaluations at Daiichi

50. Measurements of branching fractions and q2 distributions for B→πℓν and B→ρℓν decays with B→D(∗)ℓν decay tagging

Catalog

Books, media, physical & digital resources